article thumbnail

Quercetin protects against hypertensive renal injury by attenuating apoptosis: an integrated approach using network pharmacology and RNA-Seq

Journal of Cardiovascular Pharmacology

A variety of technologies, including network pharmacology, RNA-sequencing, immunohistochemistry, and Western blotting were performed to investigate its underlying mechanisms.

article thumbnail

Biosense Webster Begins Enrollment of Pivotal Trial Evaluating the Laminar Left Atrial Appendage Elimination Device?

DAIC

The study will compare the safety and efficacy of the Laminar LAAX System to commercially available left atrial appendage (LAA) closure devices, providing a potential non-pharmacologic alternative for eligible patients.  It's exciting to be part of the evolution of the latest technology into a tangible solution for treating patients.

article thumbnail

PO-04-203 LEFT CIRCUMFLEX ARTERY TO LEFT ATRIAL APPENDAGE FISTULA IN A PATIENT WITH PRIOR LEFT ATRIAL APPENDAGE CLOSURE DEVICE

HeartRhythm

Left atrial appendage (LAAC) is frequently employed as a non-pharmacological option for thromboembolic prevention in patients with atrial fibrillation (AF). With contemporary device technology, LAAC has proven to be a safe procedure. However, it is important to be vigilant for unusual complications.

article thumbnail

Anti-platelet agents inhibit platelet adhesion and aggregation on glass surface under physiological flow conditions: Toward a microfluidic platelet functional assay without additional adhesion protein modification

Journal of Cardiovascular Pharmacology

Patient administration of aspirin or (and) clopidogrel inhibited platelet adhesion and aggregation on the glass surface under flow conditions. Patient administration of aspirin or (and) clopidogrel inhibited platelet adhesion and aggregation on the glass surface under flow conditions.

article thumbnail

Study in JAHA Links Hello Heart Usage to Significant Reductions in Blood Pressure, Cholesterol, and Weight

DAIC

The study, “Comprehensive Cardiovascular Risk Factor Control with a Mobile Health Cardiovascular Risk Self-Management Program,” highlights the potential use of digital health technology in the comprehensive control of risk factors for cardiovascular disease (CVD), the leading cause of death and disability in the United States. were female.

article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

article thumbnail

Changing Landscape of Cardiovascular Diagnosis | Google AI

Wellnest

Alun Hughes, professor of Cardiovascular Physiology and Pharmacology at London’s UCL, said Google’s approach sounded credible because of the “long history of looking at the retina to predict cardiovascular risk.” It is only slightly lower than the commonly used blood test method, which has an accuracy rate of 72%.